Somatic reversion in CD137 deficiency correlating with Epstein-Barr virus control and clinical improvement


Por: Batlle-Maso, L, Pulido, JP, Esteve-Codina, A, Perurena-Prieto, J, Franco-Jarava, C, Aguilo-Cucurull, A, Martínez-Gallo, M, Cea, C, Rodriguez-Aliberas, M, Soler-Palacín, P, Casals, F, Velao, SR, Torrent, M, Alsina, L and Colobran, R

Publicada: 28 nov 2025 Ahead of Print: 28 nov 2025
Resumen:
Epstein-Barr virus (EBV) is an oncogenic virus ubiquitous in human populations. CD8 T cells play a crucial role in establishing a strong anti-EBV immune response. Among the various inborn errors of immunity (IEI) showing a restricted vulnerability to EBV, TNFRSF9 (CD137, 4-1BB) deficiency was described in 2019 in patients with chronic EBV viremia and EBV-associated lymphoproliferative diseases. We here investigated a patient with a history of chronic EBV infection and CD137 deficiency who had previously undergone transplantation from her HLA-identical brother. We found that the brother was also a homozygous carrier of the same TNFRSF9 variant, explaining the patient's inability to control EBV after transplantation. Remarkably, during a period of spontaneous clinical improvement and EBV control, we detected two somatic variants in the patient, which resulted in the emergence of two independent revertant CD8 T cell clones that accounted for up to 20% of CD8 T cells in peripheral blood. Using single cell RNA sequencing we demonstrated that both revertant clones originated post-transplant from donor-derived cells. We report here the first described case of a somatic reversion phenomenon in TNFRSF9 deficiency, correlating with clinical improvement and paving the way for future gene therapy strategies for this IEI.

Filiaciones:
Batlle-Maso, L:
 Vall Hebron Barcelona Hosp Campus, Vall Hebron Res Inst VHIR, Translat Immunol, Barcelona, Catalonia, Spain

 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

Pulido, JP:
 Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain

 Hosp Clin Barcelona, Muscle Res & Mitochondrial Funct Grp, IDIBAPS, , Catalonia, Barcelona, Spain

 CIBERER, Barcelona, Catalonia, Spain

:
 Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain

 Univ Barcelona UB, Barcelona, Catalonia, Spain

Perurena-Prieto, J:
 Vall Hebron Barcelona Hosp Campus, Vall Hebron Res Inst VHIR, Translat Immunol, Barcelona, Catalonia, Spain

 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

 Hosp Univ Vall Hebron HUVH, Immunol Div, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

 Autonomous Univ Barcelona UAB, Dept Cell Biol Physiol & Immunol, Bellaterra, Catalonia, Spain

Franco-Jarava, C:
 Hosp Joan 23, Immunol Dept, Lab Clin ICS Camp Tarragona, Tarragona, Catalonia, Spain

Aguilo-Cucurull, A:
 Vall Hebron Barcelona Hosp Campus, Vall Hebron Res Inst VHIR, Translat Immunol, Barcelona, Catalonia, Spain

 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

 Hosp Univ Vall Hebron HUVH, Immunol Div, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

Martínez-Gallo, M:
 Vall Hebron Barcelona Hosp Campus, Vall Hebron Res Inst VHIR, Translat Immunol, Barcelona, Catalonia, Spain

 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

 Hosp Univ Vall Hebron HUVH, Immunol Div, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

 Autonomous Univ Barcelona UAB, Dept Cell Biol Physiol & Immunol, Bellaterra, Catalonia, Spain

Cea, C:
 Hosp Univ Vall Hebron HUVH, Dept Clin & Mol Genet, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

Rodriguez-Aliberas, M:
 Banc Sang & Teixits, Immunohematol Lab, Barcelona, Catalonia, Spain

Soler-Palacín, P:
 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

 Hosp Univ Vall Hebron, Childrens Hosp, Pediat Infect Dis & Immunodeficiencies Unit, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

Casals, F:
 Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Barcelona, Catalonia, Spain

 Univ Barcelona, Univ Barcelona IBUB, Inst Biomed, Barcelona, Catalonia, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Barcelona, Catalonia, Spain

 Inst Recerca St Joan Deu, Barcelona, Catalonia, Spain

Velao, SR:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Hematol Dept, IIB St Pau, Barcelona, Catalonia, Spain

 Univ Autonoma Barcelona, Josep Carreras Leukemia Res Inst, Dept Med, Barcelona, Catalonia, Spain

Torrent, M:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Hematol Dept, IIB St Pau, Barcelona, Catalonia, Spain

 Univ Autonoma Barcelona, Josep Carreras Leukemia Res Inst, Dept Med, Barcelona, Catalonia, Spain

Alsina, L:
 Hosp St Joan Deu, Allergy & Clin Immunol Dept, Clin Immunol & Primary Immunodeficiencies Unit, Barcelona, Catalonia, Spain

 Inst Recerca St Joan Deu IRSJD, Study Grp Immune Dysfunct Dis Children GEMDIP, Barcelona, Catalonia, Spain

 Univ Barcelona, Dept Cirurgia & Especialitats Medquirurg, Barcelona, Catalonia, Spain

Colobran, R:
 Vall Hebron Barcelona Hosp Campus, Vall Hebron Res Inst VHIR, Translat Immunol, Barcelona, Catalonia, Spain

 Jeffrey Modell Diagnost & Res Ctr Primary Immunode, Barcelona, Catalonia, Spain

 Hosp Univ Vall Hebron HUVH, Immunol Div, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain

 Autonomous Univ Barcelona UAB, Dept Cell Biol Physiol & Immunol, Bellaterra, Catalonia, Spain

 Hosp Univ Vall Hebron HUVH, Dept Clin & Mol Genet, Vall Hebron Barcelona Hosp Campus, Barcelona, Catalonia, Spain
ISSN: 20567944





npj Genomic Medicine
Editorial
Nature Publishing Group, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Reino Unido
Tipo de documento: Article
Volumen: 10 Número: 1
Páginas: 78-78
WOS Id: 001626298000002
ID de PubMed: 41315311
imagen Green Submitted, gold

MÉTRICAS